Results 131 to 140 of about 1,773,107 (237)

Interaction with NEGR1 affects mGlu5 cell signalling and the neuroprotection induced by the positive allosteric modulator VU0409551

open access: yesBritish Journal of Pharmacology, EarlyView.
Abstract Background and Purpose The metabotropic glutamate receptor mGlu5 plays an important role in neuronal survival and synaptic plasticity. We and others have shown that mGlu5 positive allosteric modulators (PAMs) are biased agonists, triggering the activation of neuroprotective pathways and promoting neuronal survival. As mGlu5 biased pharmacology
Jennifer D. S. Guimaraes   +14 more
wiley   +1 more source

Dietary melatonin and its benefits on cardiovascular disease

open access: yesBritish Journal of Pharmacology, EarlyView.
Cardiovascular disease remains the leading cause of mortality globally, with a disproportionate burden in low‐ and middle‐income countries. Melatonin, a hormone primarily produced by the pineal gland, exhibits notable antioxidant, anti‐inflammatory and immunomodulatory properties that may confer cardiovascular benefits.
Karabo Tisane   +2 more
wiley   +1 more source

COMPARATIVE EVALUATION OF DIFFERENT DESENSITIZING AGENTS IN VITAL TOOTH PREPARATION – A CLINICAL STUDY

open access: yes
Background: Dentinal hypersensitivity is a common complication following vital tooth preparation for fixed prosthodontic restorations, leading to postoperative discomfort and reduced patient satisfaction.
Dr. Geeta Arya   +5 more
core   +1 more source

Positive modulation of glucagon‐like peptide 1 (GLP‐1) receptor by endogenous haemorphins with implications in glucose metabolism and diabetes

open access: yesBritish Journal of Pharmacology, EarlyView.
Haemorphins act on GLP‐1 receptor (GLP‐1R) activity and signalling in a positive allosteric manner. This leads to potentiated GLP‐1‐mediated activity and signalling, as well as insulin synthesis, which may have implications for glucose metabolism and, thereby, diabetes and obesity. (The graph was created in BioRender.com).
Farheen Badrealam Khan   +13 more
wiley   +1 more source

Targeted delivery of the CB2 receptor agonist JWH‐133 via VCAM‐1‐functionalised nanoparticles attenuates atherosclerosis and reveals sex‐specific therapeutic outcomes

open access: yesBritish Journal of Pharmacology, EarlyView.
Background and Purpose Atherosclerosis, a chronic inflammatory disease characterised by lipid accumulation and endothelial dysfunction, remains a leading cause of cardiovascular morbidity and mortality. While cannabinoid 2 (CB2) receptor agonists show therapeutic promise in preclinical studies, their systemic application is hindered by poor ...
Lucía Martín‐Navarro   +3 more
wiley   +1 more source

Pulsed Electromagnetic Fields: A Novel Attractive Therapeutic Opportunity for Neuroprotection After Acute Cerebral Ischemia

open access: yesNeuromodulation: Technology at the Neural Interface, EarlyView., 2021
Abstract Objectives Acute cerebral ischemia is characterized by several pathological processes evolving during time, which contribute to the final tissue damage. Secondary processes, such as prolonged inflammatory response, impaired mitochondrial function and oxidative stress, are responsible for the progression of brain injury to the peri‐infarct area,
Fioravante Capone   +8 more
wiley   +1 more source

Highly potent, brain‐penetrant EP2 receptor antagonists for the treatment of permanent focal cerebral ischaemia in male and female mice

open access: yesBritish Journal of Pharmacology, EarlyView.
Abstract Background and Purpose Cerebral ischaemia is a leading cause of death in older adults and imposes a substantial global economic burden. Recent studies indicate that inhibiting the Gαs‐coupled EP2 receptor reduces ischaemic brain injury by modulating neuroinflammation.
Zhen Jin   +7 more
wiley   +1 more source

Characterization of endocytosis and intracellular signalling of the gastrin‐releasing peptide receptor in pruritus

open access: yesBritish Journal of Pharmacology, EarlyView.
Background and Purpose Chronic pruritus (itch) is a widespread issue affecting one in four adults, with unmet needs for effective treatment. G protein‐coupled receptors (GPCRs) are central to itch signalling and represent a major therapeutic target. Endosomal GPCR signalling introduces new avenues for understanding how GPCR activity is regulated and ...
Jeffri Retamal Santibañez   +13 more
wiley   +1 more source

Structural characterisation of the effect of 5‐chloroindole on orthosteric activation of murine 5‐HT3A receptors

open access: yesBritish Journal of Pharmacology, EarlyView.
Background and Purpose 5‐HT3 receptors play a central role in gut–brain signalling, and their hyperactivity is associated with pathologies ranging from chemotherapy‐induced nausea and vomiting to irritable bowel syndrome. While the principles governing 5‐HT3R orthosteric pharmacology are well established (spanning antagonists, partial agonists and full
Madeleine M. Stauffer   +4 more
wiley   +1 more source

Postoperative Desensitization and Desensitizing Agents

open access: yesYeditepe Dental Journal
Merve Karakaya   +2 more
openaire   +1 more source

Home - About - Disclaimer - Privacy